Eli Lilly/Boehringer Ingelheim’s Jardiance (empagliflozin) got a cardiovascular label claim approved on the back of the 2015 EMA-REG trial, which helped it become the biggest seller in the class.

THE WEEK’S MOST POPULAR CURRENT SONGS ACROSS ALL GENRES, RANKED BY STREAMING ACTIVITY FROM DIGITAL MUSIC SOURCES TRACKED BY LUMINATE, RADIO AIRPLAY AUDIENCE IMPRESSIONS AS MEASURED BY LUMINATE ...

Have top stories from The Daily Pennsylvanian delivered to your inbox every day, Monday through Friday, when Penn classes are in session ...